SERTAD1: Regulator of Cell Signaling, Adhesion and Survival (G29950)

Target Name: SERTAD1

NCBI ID: G29950

SERTAD1

SERTAD1: Regulator of Cell Signaling, Adhesion and Survival

SERTAD1 (SERTA domain-containing protein 1) is a protein that is expressed in various tissues of the body, including the brain, heart, and lungs. It is a member of the superfamily of transmembrane protein, which means that it spans the entire cell membrane and extend into the cytoplasm. SERTAD1 plays a crucial role in the structure and function of many different cellular processes in the body.

One of the most significant functions of SERTAD1 is its role in the regulation of cell signaling. SERTAD1 is a key regulator of the neurotransmitter synapse, which is the structure where neurotransmitters (such as dopamine and serotonin) release from the axon terminal of a nerve cell and bind to receptors on the dendrites of the same or other neurons. SERTAD1 is involved in the transduction of signals from the neurotransmitter receptor to the intracellular signaling pathway, which ultimately regulates the expression of genes involved in cell signaling and survival.

SERTAD1 is also involved in the regulation of cell adhesion and migration. SERTAD1 is a critical regulator of tight junctions, which are the specialized structures that mediate the movement of cells along the surface of a cell membrane. tight junctions are involved in many different cellular processes , including cell signaling, and are critical for maintaining the integrity of the intercellular space. SERTAD1 is also involved in the regulation of cell migration, which is the movement of cells from the cell body to the membrane and the formation of new tissues.

In addition to its role in cell signaling and cell adhesion, SERTAD1 is also involved in the regulation of cell survival. SERTAD1 is a regulator of the DNA damage response, which is the process by which the cell responds to DNA damage and ensures that any errors in DNA replication are corrected. This process is critical for the survival of the cell and is a hallmark of the cell cycle. SERTAD1 is also involved in the regulation of cell apoptosis, which is the process by which the cell undergoes programmed cell death. is a critical regulator of cell apoptosis, and is involved in the regulation of many different cellular processes that are necessary for cell survival.

SERTAD1 is also involved in the regulation of inflammation. SERTAD1 is a key regulator of the production of pro-inflammatory cytokines, which are important for the regulation of immune and inflammatory responses. SERTAD1 is also involved in the regulation of the production of anti-inflammatory cytokines, which work to reduce inflammation and promote the resolution of inflammatory processes.

In conclusion, SERTAD1 is a protein that plays a crucial role in the regulation of many different cellular processes in the body. Its functions include the regulation of cell signaling, cell adhesion and migration, cell survival, and inflammation. As a result, SERTAD1 is a potential drug target and a biomarker for a variety of diseases. Further research is needed to fully understand the role of SERTAD1 in the regulation of cellular processes and its potential as a drug.

Protein Name: SERTA Domain Containing 1

Functions: Acts at E2F-responsive promoters as coregulator to integrate signals provided by PHD- and/or bromodomain-containing transcription factors. Stimulates E2F1/TFDP1 transcriptional activity. Renders the activity of cyclin D1/CDK4 resistant to the inhibitory effects of CDKN2A/p16INK4A

The "SERTAD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SERTAD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets